Skip to main content
Xbrane Biopharma AB (publ) (STO:XBRANE)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.2376
-0.0128 (-5.11%)
May 23, 2025, 5:29 PM CET

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Pharmaceutical
238.73M
Log In
Log In
Log In
Log In
Upgrade
Pharmaceutical Growth
314.33%
Log In
Log In
Log In
Log In
Upgrade
Biosimilars
-
Log In
Log In
Log In
Log In
Upgrade
Administration and Unallocated
-
Log In
Log In
Log In
Log In
Upgrade
Administration and Unallocated Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Europe
210.00M
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
3034.33%
Log In
Log In
Log In
Log In
Upgrade
North America
28.70M
Log In
Log In
Log In
Log In
Upgrade
North America Growth
-43.61%
Log In
Log In
Log In
Log In
Upgrade
Asia
-
Log In
Log In
Log In
Log In
Upgrade
Asia Growth
-
Log In
Log In
Log In
Log In
Upgrade